Is DGCMF or JNJ a better dividend investment in 2026?

DGCMF currently yields 11299.44% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: DGCMF offers higher current income.

What is the dividend yield difference between DGCMF and JNJ?

DGCMF has a forward dividend yield of 11299.44% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 11297.31 percentage points.

Home › Compare › DGCMF vs JNJ

DGCMF vs JNJ: Dividend Comparison 2026

DGCMF yields 11299.44% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DGCMF wins by $183965375974701248.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DGCMF

● Live price

11299.44%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$183965375974701248.00M

Annual income

$180,817,472,251,445,500,000,000.00

Full DGCMF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — DGCMF vs JNJ

📍 DGCMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DGCMF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DGCMF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DGCMF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DGCMF

Annual income on $10K today (after 15% tax)

$960,451.98/yr

After 10yr DRIP, annual income (after tax)

$153,694,851,413,728,650,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, DGCMF beats the other by $153,694,851,413,728,650,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DGCMF + JNJ for your $10,000?

DGCMF: 50%JNJ: 50%

100% JNJ50/50100% DGCMF

Portfolio after 10yr

$91982687987350624.00M

Annual income

$90,408,736,125,722,750,000,000.00/yr

Blended yield

98.29%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DGCMF

No analyst data

Altman Z

-7.2

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DGCMF buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2026-01-23
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-12-18
Lloyd Doggett	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-12-09
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2025-11-20
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-11-13
Rich McCormick	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-11-05
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Jared Moskowitz	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-10-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDGCMFJNJ

Forward yield	11299.44% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$183965375974701248.00M ✓	$30.3K
Annual income after 10y	$180,817,472,251,445,500,000,000.00 ✓	$4,689.40
Total dividends collected	$183756313300297216.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DGCMF vs JNJ ($10,000, DRIP)

Year	DGCMF Portfolio	DGCMF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,140,644	$1,129,943.50	$10,592	$272.30	+$1.13M → DGCMF
2	$121,674,948	$120,454,459.35	$11,289	$357.73	+$121.66M → DGCMF
3	$12,138,735,895	$12,008,543,701.21	$12,123	$472.89	+$12138.72M → DGCMF
4	$1,132,629,615,725	$1,119,641,168,316.62	$13,141	$629.86	+$1132629.60M → DGCMF
5	$98,847,813,220,990	$97,635,899,532,164.06	$14,408	$846.81	+$98847813.21M → DGCMF
6	$8,069,284,075,259,292	$7,963,516,915,112,835.00	$16,021	$1,151.60	+$8069284075.24M → DGCMF
7	$616,193,986,538,544,000	$607,559,852,578,016,500.00	$18,122	$1,588.22	+$616193986538.53M → DGCMF
8	$44,019,174,578,897,410,000	$43,359,847,013,301,170,000.00	$20,930	$2,228.20	+$44019174578897.39M → DGCMF
9	$2,941,966,096,500,683,000,000	$2,894,865,579,701,262,400,000.00	$24,792	$3,191.91	+$2941966096500683.00M → DGCMF
10	$183,965,375,974,701,240,000,000	$180,817,472,251,445,500,000,000.00	$30,274	$4,689.40	+$183965375974701248.00M → DGCMF

DGCMF vs JNJ: Complete Analysis 2026

DGCMF — Stock

Digital Commodities Inc. operates as an investment issuer in Canada. It invests in digital and physical non-fiat assets, and businesses and private and publicly listed entities with a focus on hard commodities, cryptocurrencies, and the resource sector. The company was formerly known as Digital Commodities Capital Corp. and changed its name to Digital Commodities Inc. in September 2025. Digital Commodities Inc. is based in Vancouver, Canada.

Full DGCMF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this DGCMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DGCMF vs SCHD DGCMF vs JEPI DGCMF vs O DGCMF vs KO DGCMF vs MAIN DGCMF vs ABBV DGCMF vs MRK DGCMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.